Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2021 16:05 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend

First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
January 18, 2021 21:50 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Announces Pricing of Public Offering of Common Stock

GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of an underwritten public...
December 08, 2020 16:15 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York

Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day Doylestown, PA, Dec. 08, 2020 (GLOBE...
November 16, 2020 08:30 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020

DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
October 23, 2020 08:30 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing

DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to...